Clinical Trials Directory

Trials / Completed

CompletedNCT01562145

Elevated Plasma Levels of TIMP-1 in Patients With Rotator Cuff Tear

Status
Completed
Phase
Study type
Observational
Enrollment
34 (actual)
Sponsor
University Hospital, Linkoeping · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The aim of the study was to investigate the levels of matrixmetalloproteinases and their inhibitors in blood samples from patients with rotator cuff tears and compare with blood samples from healthy matched controls.

Detailed description

Background: Extracellular matrix remodeling is altered in rotator cuff tears, partly due to altered expression of matrix metalloproteinases (MMPs) and their inhibitors. It is unclear if this altered expression can be traced as changes in plasma protein levels. We measured the plasma level of MMPs and their tissue inhibitors (TIMPs) in patients with rotator cuff tears. Material and methods: Blood samples were collected from 17 patients, median 61 (range 39-77) years, with sonographically verified rotator cuff tears (partial- or full-thickness). These were compared with 16 gender and age matched control persons with sonographically intact rotator cuffs. Plasma levels of MMPs and TIMPs were measured simultaneously using Luminex technology.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood samplingFour mL venous blood samples were collected from all study participants after inclusion

Timeline

Start date
2009-01-01
Primary completion
2010-02-01
Completion
2010-02-01
First posted
2012-03-23
Last updated
2012-03-26

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01562145. Inclusion in this directory is not an endorsement.